Mehrukh Zehravi | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Mehrukh Zehravi | Toxicology and Pharmaceutical Science | Best Researcher Award

Buraydah Private colleges, Saudi Arabia

She is a highly motivated and experienced Clinical Pharmacy lecturer with a proven track record of delivering engaging and effective teaching to both undergraduate and graduate students. With in-depth knowledge of Clinical Pharmacy, therapeutics, medication management, patient counseling, and drug safety, she excels in developing and delivering curricula, supervising practical training sessions, and conducting research to advance the field of clinical pharmacy. She collaborates effectively with other healthcare professionals to improve patient care and outcomes. A passionate and dedicated educator, she is committed to providing students with the knowledge and skills they need to succeed in their careers as pharmacists.

Professional Profile

Education

She is currently pursuing a Ph.D. in Pharmaceutical Sciences at the University of Karachi, Pakistan, expected to complete in 2025. She holds a Master’s in Pharmaceutical Sciences, earned between August 2007 and December 2009, and a Bachelor of Pharmacy, completed between January 2002 and December 2005, both from the University of Karachi. Throughout her career, she has received a letter of appreciation from the University for her on-field Pharmacy Training from 2016 to 2023. She designed and implemented a new clinical pharmacy curriculum that enhanced student learning and engagement, leading to improved student performance and feedback. She has published multiple research articles in high-impact, peer-reviewed journals, demonstrating her expertise in clinical pharmacy and contributing to the field’s advancement. Additionally, she has mentored and supervised graduate students in clinical pharmacy research, helping them develop their research skills and publish their work in reputable journal

Professional Experience

She has actively participated in various conferences and workshops to enhance her professional development. In 2016, she attended a workshop on “Coaching Conversation Approaches for the Workplace” at Prince Sattam Bin Abdul Aziz University. She also participated in the conference on “WHO Prescribing Indicators & Its Compliance by General Practitioners of Lahore, Pakistan,” conducted by the 4th China Pharmaceutical University International Students Academic Forum at the Conference Center Jiangning Campus in April 2017. She attended the PPA International Conference Seminar on “Pharmacists Voice: Patient Safety Starts with Me” at the University of Central Punjab, Pakistan. Additionally, she was involved in the 3rd Annual Conference of Rashid Latif College of Pharmacy, held at Rashid Latif Medical College, University of Health Sciences, Lahore, Pakistan. She also took part in the “Perspective & Dimensions of Drug Product Bioequivalence in the 21st Century” event, organized by the University of Karachi in December 2015

CONFERENCES & WORKSHOPS

She has actively participated in various conferences and workshops to enhance her professional development. In 2016, she attended a workshop on “Coaching Conversation Approaches for the Workplace” at Prince Sattam Bin Abdul Aziz University. She also participated in the conference on “WHO Prescribing Indicators & Its Compliance by General Practitioners of Lahore, Pakistan,” conducted by the 4th China Pharmaceutical University International Students Academic Forum at the Conference Center Jiangning Campus in April 2017. She attended the PPA International Conference Seminar on “Pharmacists Voice: Patient Safety Starts with Me” at the University of Central Punjab, Pakistan. Additionally, she was involved in the 3rd Annual Conference of Rashid Latif College of Pharmacy, held at Rashid Latif Medical College, University of Health Sciences, Lahore, Pakistan. She also took part in the “Perspective & Dimensions of Drug Product Bioequivalence in the 21st Century” event, organized by the University of Karachi in December 2015

CITATIONS RESEARCH GATE

  • Research Interest Score – 1151
  • Citations –  1508
  • h-Index –    23

CITATION GOOGLE SCHOLAR:

  • Citations –   1516
  • h- Index –      22
  • i-10 Index –    47

Book Chapters:

  1. F Islam, MR Islam, MH Nafady, M Faysal, SL Khan, M Zehravi, Pharmacogenomics of immunosuppressants, Publisher: Elsevier Inc. Pharmacogenomics, 323-344, 2023/11. Academic Press
  2. Karthika, C. et al. (2023). The Role of Curcumin as an Anti-Aging Compound. In: Rizvi, S.I. (eds) Emerging Anti-Aging Strategies. Online 31st January 2023, Springer, Singapore.
  3. Entitled – Basic Laboratory Methods of Pharmacology & Toxicology, Published in Sept 2021, ISBN-976-81-7622-495
  4. C Karthika, M Zehravi, R Akter, MH Rahman, Stretegic design of Nano carrier system for Nutraceutical, CRC Press, Handbook of Nanotechnology in Nutraceuticals, 79-96
  5. Entitled – Pharmacophore Modelling & its significance in Drug Discovery, CRC Press Nanotechnology in Nutraceuticals, Feb 2022, Accepted by the Editor, accepted for the publication.

Publications Top Noted

 

Junjie Liu | pharmaceutics | Best Researcher Award

Published on by Shen Awards

Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Profile

Education🎓 

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫 

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬 

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.

 

Mr. Waseem Ali | Drug Repurposing | Best Researcher Award

Published on by Shen Awards

Mr. Waseem Ali : Leading Researcher in Drug Repurposing

PhD Student at Drug Repurposing, Guru Nanak Dev Engineering College, Ludhiana, Punjab, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Waseem Ali achieved academic success throughout his educational journey. In 2011, he secured a First Division in the Matriculation examination from the C.B.S.E. Board, India, with a focus on Science. Continuing his impressive performance, he obtained a Second Division in the Higher Secondary examination in 2013 from the same board. In 2016, he graduated with a Second Division from C.C.S. University, Meerut, specializing in Biotechnology with a focus on molecular biology. His commitment to excellence was further demonstrated in 2018 when he completed his Post Graduation with a First Division from Jamia Hamdard, New Delhi, specializing in Biotechnology with a focus on molecular biology.

Experience:

Mr. Waseem Ali has held several positions in the field of Biotechnology and molecular biology. From 05-08-2022 to 29-12-2022, he served as a Project Assistant at Jamia Hamdard, where he contributed to a project aiming to decipher novel targets of M.tb pathogenesis that manipulate host defenses in compromised hosts. The identified targets may be utilized to develop anti-TB agents effective against drug-resistant isolates. His supervisor during this time was Dr. Javaid A Shaikh. Prior to this, from 15-01-2019 to 04-08-2022, Mr. Ali worked as a Project Assistant at Jamia Hamdard, focusing on determining the effect of FDA-approved drugs against M.tb. He evaluated the efficacy of selected drugs against M.tb in vitro and ex vivo, using molecular docking, simulation, and biophysical methods to predict their binding affinity and effect with target proteins. His supervisors during this period were Prof. S. E. Hasnain and Dr. Sonam Grover. Currently, since 04-01-2021, Mr. Ali is pursuing his Ph.D. at Jamia Hamdard under the guidance of Prof. S. E. Hasnain and Dr. Sonam Grover, focusing on research related to drug repurposing.

Publications:

Mr. Waseem Ali has co-authored several research papers in reputable journals. In “Microbes and Infection” in 2023, he collaborated with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Isha Pahuja, Rahul Sharma, Ved Prakash Dwivedi, Meetu Agarwa, and Sonam Grover on a paper titled “Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA,” which was published on 5.8. In “Molecular Informatics” in 2023, he worked with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Rahul Sharma, Meetu Agarwal, Javaid Ahmad Sheikh, Abhinav Grover, and Sonam Grover on a paper titled “Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors,” which was published on 4.05. Additionally, in “Computational and Structural Biotechnology Journal” in 2021, he contributed to a paper titled “Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis,” co-authored with Pooja Singh, Salma Jamal, Faraz Ahmed, Najumu Saqib, Seema Mehra, Deodutta Roy, Nasreen Z Ehtesham, and Seyed E Hasnain. In “Journal of Translational Medicine” in 2021, Mr. Ali collaborated with Salma Jamal, Priya Nagpal, Abhinav Grover, and Sonam Grover on a paper titled “Computational models for the prediction of adverse cardiovascular drug reactions,” which was published on 8.44.